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ABSTRACT 
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk 
assessments carried out by the competent authority of the rapporteur Member State, the United Kingdom, for the 
pesticide  active  substance  eugenol  are  reported.    The  context  of  the  peer  review  was  that  required  by 
Commission Regulation (EU) No 188/2011.  The conclusions were reached on the basis of the evaluation of the 
representative uses of eugenol as a fungicide on table and wine grapes. The reliable endpoints concluded as 
being appropriate for use in regulatory risk assessment, derived from the available studies and literature in the 
dossier  peer  reviewed,  are  presented.    Missing  information  identified  as  being  required  by  the  regulatory 
framework is listed.  Concerns are identified.   
© European Food Safety Authority, 2012 
KEY WORDS 
eugenol, peer review, risk assessment, pesticide, fungicide 
   
                                                       
1  On request from the European Commission, Question No EFSA-Q-2011-00903, approved on 15 October 2012. 
2   Correspondence: pesticides.peerreview@efsa.europa.eu Peer review of the pesticide risk assessment of the active substance eugenol 
 
EFSA Journal 2012;10(11):2914    2 
SUMMARY 
Eugenol is a new active substance for which in accordance with Article 6(2) of Council Directive 
91/414/EEC the United Kingdom (hereinafter referred to as the „RMS‟) received an application from 
Eden  Research  PLC  for  approval.    Complying  with  Article  6(3)  of  Directive  91/414/EEC,  the 
completeness of the dossier was checked by the RMS.  The European Commission recognised in 
principle the completeness of the dossier by Commission Implementing Decision 2011/266/EU of 2 
May 2011. 
The RMS provided its initial evaluation of the dossier on eugenol in the Draft Assessment Report 
(DAR), which was received by the EFSA on 30 June 2011.  The peer review was initiated on 11 July 
2011 by dispatching the DAR for consultation of the Member States and the applicant Eden Research 
PLC.  
Following consideration of the comments received on the DAR, it was concluded that EFSA should 
conduct an expert consultation in the area of environmental fate and behaviour and EFSA should 
adopt a conclusion on whether eugenol can be expected to meet the conditions provided for in Article 
5  of  Directive  91/414/EEC,  in  accordance  with  Article  8  of  Commission  Regulation  (EU)  No 
188/2011. 
The  conclusions  laid  down  in  this  report  were  reached  on  the  basis  of  the  evaluation  of  the 
representative uses of eugenol as a fungicide on table and wine grapes, as proposed by the applicant. 
Full details of the representative uses can be found in Appendix A to this report. 
In the area of identity, physical/chemical/technical properties and methods of analysis data gaps were 
identified for methods for soil, water, and air as well as further data on the relevant impurity. 
In the area of mammalian toxicology, methyleugenol was identified as a genotoxic and carcinogenic 
impurity, for which no acceptable level without toxicological concern could be established (critical 
area of concern) 
In the residue section, a data gap was identified to provide additional storage stability data to cover the 
maximum  storage  time  interval  of  the  samples  in  the  residue  trials.  In  view  of  its  genotoxic 
carcinogenic properties, a data gap was identified to determine the occurrence of methyleugenol as a 
residue in grapes with a sufficiently low limit of quantification when the formulated product is applied 
in accordance with the representative use. A reliable assessment of the consumer exposure to residues 
of methyleugenol in grapes is currently not possible. This issue was identified as a critical area of 
concern. 
Several data gaps were identified in the environmental fate and behaviour section. On the basis of the 
available data, a critical area of concern has been identified for potential groundwater contamination 
by  eugenol.  The  environmental  risk  assessment,  including  the  groundwater  exposure  assessment, 
cannot  be  concluded  for  potential  metabolites  of  eugenol  and  in  particular  for  the  impurity  and 
potential environmental metabolite methyleugenol.  
Data daps were identified to further consider the short-term and long-term risk to insectivorous birds 
and the risk to aquatic organisms. A low risk was concluded for earthworms, honeybees, non-target 
arthropods, soil microorganisms, terrestrial non-target plant and methods for sewage treatment plants. 
 Peer review of the pesticide risk assessment of the active substance eugenol 
 
EFSA Journal 2012;10(11):2914    3 
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 3 
Background .............................................................................................................................................. 4 
The active substance and the formulated product .................................................................................... 6 
Conclusions of the evaluation .................................................................................................................. 6 
1.  Identity, physical/chemical/technical properties and methods of analysis ...................................... 6 
2.  Mammalian toxicity  ......................................................................................................................... 6 
3.  Residues ........................................................................................................................................... 7 
4.  Environmental fate and behaviour ................................................................................................... 8 
5.  Ecotoxicology .................................................................................................................................. 8 
6.  Overview of the risk assessment of compounds listed in residue definitions triggering assessment 
of effects data for the environmental compartments .............................................................................. 10 
6.1.  Soil ........................................................................................................................................ 10 
6.2.  Groundwater ......................................................................................................................... 10 
6.3.  Surface water and sediment .................................................................................................. 11 
6.4.  Air ......................................................................................................................................... 11 
7.  List of studies to be generated, still ongoing or available but not peer reviewed .......................... 12 
8.  Particular conditions proposed to be taken into account to manage the risk(s) identified  ............. 13 
9.  Concerns ........................................................................................................................................ 13 
9.1.  Issues that could not be finalised .......................................................................................... 13 
9.2.  Critical areas of concern ....................................................................................................... 13 
9.3.  Overview of the concerns identified for each representative use considered ....................... 14 
References .............................................................................................................................................. 15 
Appendices ............................................................................................................................................. 17 Peer review of the pesticide risk assessment of the active substance eugenol 
 
EFSA Journal 2012;10(11):2914    4 
BACKGROUND 
In  accordance  with  Article  80(1)(a)  of  Regulation  (EC)  No  1107/2009,
3  Council  Directive 
91/414/EEC
4 continues to apply with respect to the procedure and conditions for approval for  active 
substances for which a decision recognising in principle the completeness of the dossier was adopted 
in accordance with Article 6(3) of that Directive before 14 June 2011. 
Commission Regulation (EU) No 188/2011
5 (hereinafter referred to as „the Regulation‟) lays down the 
detailed rules for the implementation of Council Directive 91/414/EEC as regards the procedure for 
the assessment of active substances which were not on the market on 26 July 1993.  This regulates for 
the European Food Safety Authority (EFSA) the procedure for organising the consultation of Member 
States and the applicant for comments on the initial evaluation in the Draft Assessment Report (DAR) 
provided by the rapporteur Member State (RMS), and the organisation of an expert consultation, 
where appropriate.   
In accordance with Article 8 of the Regulation, EFSA is required to adopt a conclusion on whether the 
active substance is expected to meet the conditions provided for in Article 5 of Directive 91/414/EEC 
within 4 months from the end of the period provided for the submission of written comments, subject 
to an extension of 2 months where an expert consultation is necessary, and a further extension of upto 
8 months where additional information is required to be submitted by the applicant(s) in accordance 
with Article 8(3).  
In accordance with Article 6(2) of Council Directive 91/414/EEC the United Kingdom (hereinafter 
referred to as the „RMS‟) received an application from Eden Research PLC for approval of the active 
substance eugenol. Complying with Article 6(3) of Directive 91/414/EEC, the completeness of the 
dossier  was  checked  by  the  RMS.    The  European  Commission  recognised  in  principle  the 
completeness of the dossier by Commission Implementing Decision 2011/266/EU
6. 
The RMS provided its initial evaluation of the dossier on eugenol in the DAR, which was received by 
the EFSA on 30 June 2011 (United Kingdom, 2011). The peer review was initiated on 11 July 2011 by 
dispatching the DAR  to Member States and the  applicant Eden Research PLC for consultation and 
comments.  In addition, the EFSA conducted a public consultation on the DAR.    The comments 
received were collated by the EFSA and forwarded to the RMS for compilation and evaluation in the 
format of a Reporting Table.  The applicant was invited to respond to the comments in column 3 of the 
Reporting Table. The comments and the applicant‟s response were evaluated by the RMS in column 3. 
The need for expert consultation and the necessity for additional information to be submitted by the 
applicant in accordance with Article 8(3) of the Regulation were considered in a telephone conference 
between the EFSA, the RMS, and the European Commission on 21 October 2011. On the basis of the 
comments received, the applicant‟s response to the comments and the RMS‟s evaluation thereof it was 
concluded that additional information should be requested from the applicant and the EFSA should 
organise an expert consultation in the area of environmental fate and behaviour. 
The  outcome  of  the  telephone  conference,  together  with  EFSA‟s  further  consideration  of  the 
comments is reflected in the conclusions set out in column 4 of the Reporting Table. All points that 
                                                       
3 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing 
of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ No L 309, 
24.11.2009, p. 1-50. 
4 Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 230, 
19.8.1991, p. 1-32, as last amended.  
5 Commission Regulation (EU) No 188/2011 of 25 February 2011 laying down detailed rules for the  implementation of 
Council Directive 91/414/EEC as regards the procedure for the assessment of active substances which were not on the market 
2 years after the date of notification of that Directive. OJ No L 53, 26.2.2011, p. 51-55. 
6 Commission Decision 2011/266/EU of 2 May 2011 recognising in principle the completeness of the dossier submitted for 
detailed examination in view of the possible inclusion of beta -cypermethrin, eugenol, geraniol and thymol in Annex I to 
Council Directive 91/414/EEC. OJ No L 114, 4.5.2011, p. 3-4. Peer review of the pesticide risk assessment of the active substance eugenol 
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were identified as unresolved at the end of the comment evaluation phase and which required further 
consideration, including those issues to be considered in an expert consultation, and the additional 
information  to  be  submitted  by  the  applicant,  were  compiled  by  the  EFSA  in  the  format  of  an 
Evaluation Table. 
The conclusions arising from the consideration by the EFSA, and as appropriate by the RMS, of the 
points identified in the Evaluation Table, together with the outcome of the expert consultation where 
this took place, were reported in the final column of the Evaluation Table. 
A final consultation on the conclusions arising from the peer review of the risk assessment took place 
with Member States via a written procedure in September 2012.   
This conclusion report summarises the outcome of the peer review of the risk assessment on the active 
substance and the representative formulation evaluated on the basis of the representative use as a 
fungicide on table and wine grapes, as proposed by the applicant. A list of the relevant end points for 
the  active  substance  as  well  as  the  formulation  is  provided  in  Appendix  A.  In  addition,  a  key 
supporting document to this conclusion is the Peer Review Report, which is a compilation of the 
documentation developed to evaluate and address all issues raised in the peer review, from the initial 
commenting  phase  to  the  conclusion.  The  Peer  Review  Report  (EFSA,  2012b)  comprises  the 
following documents, in which all views expressed during the course of the peer review, including 
minority views, can be found: 
•  the comments received on the DAR, 
•  the Reporting Table (21 October 2011),  
•  the Evaluation Table (5 October 2012), 
•  the report of the scientific consultation with Member State experts, 
•  the comments received on the assessment of the additional information (where relevant), 
•  the comments received on the draft EFSA conclusion. 
Given the importance of the DAR including its addendum (compiled version of June 2012 containing 
all  individually  submitted  addenda  (United  Kingdom,  2012))  and  the  Peer  Review  Report,  both 
documents are considered respectively as background documents A and B to this conclusion.  Peer review of the pesticide risk assessment of the active substance eugenol 
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THE ACTIVE SUBSTANCE AND THE FORMULATED PRODUCT 
Eugenol is the given name for 4-allyl-2-methoxyphenol (IUPAC). 
The representative formulated product for the evaluation is „Mevalone 3AEY‟ a capsule suspension 
(CS) containing 3.2 % eugenol, 6.4 % geraniol and 6.4% thymol. 
The representative use evaluated comprises outdoor foliar spraying against Botrytis on table and wine 
grapes. Full details of the GAP can be found in the list of end points in Appendix A.  
CONCLUSIONS OF THE EVALUATION 
1.  Identity, physical/chemical/technical properties and methods of analysis 
The  following  guidance  documents  were  followed  in  the  production  of  this  conclusion: 
SANCO/3030/99  rev.4  (European  Commission,  2000)  and  SANCO/825/00  rev.  8.1  (European 
Commission, 2004a). 
The minimum purity of eugenol is 990 g/kg. Eugenol contains the relevant impurity methyleugenol at 
a  maximum  level  of  0.05  g/kg  (0.005%).  When  analysing  the  formulated  product  during  storage 
studies, it was found that the initial and after storage samples contained up to 5 times higher levels of 
methyleugenol than would be expected from the technical specification. A data gap was identified to 
address this issue. Methyleugenol is a relevant impurity because it is a genotoxic carcinogen and a 
critical area of concern was identified. 
The main data regarding the identity of eugenol and its physical and chemical properties are given in 
Appendix A. 
Due to the nature of the compound no methods are required for products of plant and animal origin. 
However, for soil and water methods are required (see section 4). For air a method of analysis is 
required as there is an exposure scenario. Methods of analysis for body fluids and tissues are not 
required as the active substance is not considered as toxic or very toxic.   
2.  Mammalian toxicity 
The  following  guidance  document  was  followed  in  the  production  of  this  conclusion: 
SANCO/222/2000 rev. 7 (European Commission, 2004b). 
In the technical specification, the impurity methyleugenol is identified as a genotoxic carcinogen and 
an  acceptable  level  without  toxicological  concern  cannot  be  established  (European  Commission, 
2001).  A data gap and critical area of concern are identified.  
It is noted that acceptable maximum levels of exposure to methyleugenol were set in other regulatory 
frameworks;  however  the  basis  for  the  derivation  of  these  thresholds  is  not  available  and  could 
therefore not be assessed. 
Rapidly and extensively absorbed, eugenol is excreted almost exclusively in urine. The available acute 
toxicity  data indicate  that  eugenol  is  harmful  if  swallowed  (R22  proposed,  equivalent  to  H302
7), 
irritant for the skin and the eyes (R36/38 proposed, equivalent to H315 and H319
7),  and  a  skin 
sensitiser (R43 proposed, equivalent to H317
7). In a 13-week oral study with rats, a NOAEL of 600 
mg/kg bw per day was triggered by a decreased body weight gain (  10 %) in males. Based on the 
available data, eugenol is unlikely to be genotoxic at exposures that do not result in cytotoxicity and 
                                                       
7 It should be noted that classification is formally proposed and decided in accordance with Regulation (EC) No 1272/2008 
(Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, 
labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and 
amending Regulation (EC) No 1907/2006. OJ No L 353, 31.12.2008. p. 1-1355).  Proposals for classification made in the 
context of the evaluation procedure under Regulation (EC) No 1107/2009 are not formal proposals. Peer review of the pesticide risk assessment of the active substance eugenol 
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saturation of conjugation pathways. In the 2-year studies with rats and mice there was no evidence of a 
carcinogenic potential relevant to humans, and the systemic NOAEL is 300 mg/kg bw per day for rats 
and 450 mg/kg bw per day for mice. No multigeneration study was provided for eugenol and it was 
not considered necessary based on the available data. In the DAR, developmental toxicity studies 
performed  with  clove  oil  (of  unknown  source  and  purity)  were  evaluated.  However,  newer 
developmental toxicity studies showing more adverse endpoints for eugenol were evaluated for clove 
oil (EFSA, 2012a). In these studies with rats and rabbits, the maternal and developmental NOAELs 
were 100 and 250 mg/kg bw per day respectively, for both species, without teratogenic effect. No 
indication of a neurotoxic potential was observed in the available studies with eugenol.  
Based on the maternal NOAEL in the developmental studies, and applying an uncertainty factor of 
100, the Acceptable Daily Intake (ADI) and Acceptable Operator Exposure Level (AOEL) are 1.0 
mg/kg bw per day. No Acute Reference Dose (ARfD) is considered necessary.  
The exposure estimates with the German model, UK POEM and EUROPOEM for vehicle-mounted 
sprayers are below the AOEL for unprotected operators. For hand-held use, estimates are within the 
AOEL for unprotected operators using the German model and UK POEM. The bystander exposure to 
spray drift during application and the resident exposure to drift fall-out and to vapour post-application 
(taking into account the high volatility of eugenol) are estimated to be below the AOEL. The worker 
exposure estimates according to EUROPOEM II are below the AOEL, even when considering four 
applications and without dissipation between treatments.  However, since the impurity methyleugenol 
is identified as a genotoxic carcinogen and an acceptable level without toxicological concern cannot be 
established, the human health risk assessment cannot be concluded. 
3.  Residues 
The  assessment  in  the  residue  section  below  is  based  on  the  guidance  documents  listed  in  the 
document  1607/VI/97  rev.2  (European  Commission,  1999),  and  the  JMPR  recommendations  on 
livestock burden calculations stated in the 2004 and 2007 JMPR reports (JMPR, 2004 and 2007). 
Plant metabolism studies were not submitted as eugenol occurs naturally in plants and very limited 
information from the published literature was reported in the DAR. Data on the natural background 
levels of eugenol in grapes from retail samples were also submitted and gave indication of residue 
levels  far  below  0.05  mg/kg  (validated  LOQ  of  the  method).  EFSA  is  of  the  opinion  that  no 
metabolism  data  are  required  to  conduct  a  reliable  consumer  risk  assessment  with  regard  to  the 
eugenol residues if the submitted residue trials are considered as acceptable. 
Sufficient  residue  trials  on  grapes  in  compliance  with  the  representative  use  were  submitted  and 
demonstrated that the use of eugenol as a plant protection product did not result in residue levels 
higher than the LOQ of the analytical method (0.05 mg/kg) both in the treated and control samples. 
EFSA was unable to conclude on the storage stability of residues of eugenol in grapes within 1 month 
of  storage  based  on  the  submitted  studies  as  the  results  were  shown  to  be  contradictory.  The 
acceptability of these trials is therefore pending the outcome of new storage stability data to cover the 
maximum storage time interval of eugenol in the samples from the residue trials, and a data gap is 
identified.  
In view of the genotoxic carcinogenic properties of methyleugenol, and because of the higher levels of 
methyleugenol  recovered  in  the  formulated  product  than  would  be  expected  in  the  technical 
specification  (section  1),  relevant  data  should  be  provided  to  determine  the  occurrence  of 
methyleugenol  as  a  residue  in  grapes  with  a  sufficiently  low  limit  of  quantification  when  the 
formulated  product  is  applied  in  accordance  with  the  representative  use  (data  gap).    A  reliable 
assessment of the consumer exposure to residues of methyleugenol in grapes is currently not possible.  
EFSA performed a provisional consumer risk assessment with regard to eugenol residues and no 
intake concern was identified (<1% of the ADI).  Nevertheless, the overall consumer exposure cannot Peer review of the pesticide risk assessment of the active substance eugenol 
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be concluded with regard to the genotoxic carcinogenic methyleugenol and this issue was identified as 
a critical area of concern. 
4.  Environmental fate and behaviour 
No data or information has been submitted on the route and rate of degradation of eugenol in soil. 
Methyleugenol  is  considered  a  toxicologically  relevant  compound.  Methylation  of  eugenol  was 
thought possible as methylation is a transformation that has been frequently observed in soil for other 
similar chemicals. In particular, methylation has been observed in soil for a number of other phenols. 
Therefore, during the peer review, it was agreed that at least a soil incubation study under aerobic 
conditions should be performed. In this study, methyleugenol must be analysed for (both in soil and 
volatile traps), with an appropriate low limit of quantification (significantly below 5% equivalent of 
the  dosed  eugenol  concentration  in  soil).  Additionally,  during  the  peer  review  a  data  gap  was 
identified for information to address the potential for photolysis of eugenol in soil. For the exposure 
assessment of the parent eugenol, it was accepted that worst case default DT50 following REACH 
guidance (ECHA, 2010) will result in a sufficiently conservative assessment. PECs soil have been 
calculated by the RMS based on this default value and 70 % crop interception.  
No data on the mobility of eugenol were presented in the dossier. Different eugenol QSAR Koc 
estimations were considered during the peer review. These estimations revealed the high uncertainty 
associated  with  them,  and  were  not  considered  appropriate  for  the  environmental  assessment. 
Therefore, it was agreed that a batch soil adsorption/desorption study in four soils must be performed 
with eugenol. In the absence of  experimental data, it was agreed to use worst case estimates for 
environmental modelling (Koc = 10 mL/g (1/n = 0.9) for PECSW and PECGW and Koc = 10000 mL/g 
(1/n = 0.9) for PECsed) to represent an appropriate worst case for each of the compartments. 
Neither  hydrolysis  nor  aqueous  photolysis  of  eugenol  has  been  investigated.  The  waiver  for  the 
hydrolysis  study,  based  on  eugenol‟s  chemical  structure,  was  accepted  during  the  peer  review. 
Eugenol is consequently considered stable to hydrolysis in the range of normal environmental pHs. A 
data gap was identified for  a study to address  aqueous photolysis of eugenol. No water/sediment 
dissipation/degradation  test  is  available  for  eugenol.  Eugenol  has  been  shown  to  be  readily 
biodegradable according to the OECD 301 F test. 
FOCUS Step 1 and Step 2 PEC SW/sed (FOCUS, 2001) have been calculated by the RMS based on 
the worst case default input parameters following REACH guidance (ECHA, 2010). As indicated 
above, high and low Koc values were used to represent an appropriate worst case for each of the 
compartments. 
The peer review agreed that a first estimation of the potential groundwater contamination by eugenol 
could  be  obtained  by  FOCUS  GW  calculation  (FOCUS,  2009)  of  the  20  years  80
th  percentile 
concentration  of  eugenol  in  the  leachate  at  1  m  depth  using  default  input  parameters  following 
REACH guidance (ECHA, 2010) for DT50 and, as indicated above, a low Koc value to address the 
worst  case  for  groundwater.  Since  the  groundwater  exposure  assessment,  performed  with  default 
values, shows that the regulatory limit of 0.1 µg/L is exceeded in nine of the nine scenarios, a data gap 
has been identified for a rate of degradation study of eugenol in four different soils under aerobic 
conditions.  Furthermore,  a  critical  area  of  concern  has  been  identified  for  potential  groundwater 
contamination by eugenol.  
5.  Ecotoxicology 
The risk assessment was based on the following documents: European Commission (2002a, 2002b, 
2002c), SETAC (2001), and EFSA (2009). 
Pending on the outcome of the data gap identified in the fate and behaviour risk assessment, the 
ecotoxicological risk assessment should be reconsidered for methyleugenol. Peer review of the pesticide risk assessment of the active substance eugenol 
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The ecotoxicological studies provided were conducted with the formulated product „Mevalone 3AEY‟ 
containing the active substances eugenol, thymol and geraniol, and studies with the active substance 
eugenol were available only on fish, Daphnia and algae. 
The  acute  risk  for  small  insectivorous  birds  was  assessed  as  low.  It  is  noted  that  the  short-term 
endpoint  for  birds  was  considered  not  valid  within  the  peer  review  of  thymol  and  therefore  for 
consistency  was  not  used  for  the  short-term  risk  assessment  of  eugenol.  No  chronic  study  was 
available to address the long-term risk to birds. As a justification, the applicant argued that birds are 
naturally exposed to eugenol because it is a naturally occurring substance present in the environment. 
The applicant also argued that eugenol is very volatile and is rapidly degraded in the air. However, no 
data were included in the fate and behaviour section to support such statements in relation to the 
background levels in the environment and degradation in the biosphere. Therefore, a data gap was 
identified  to  further  consider  the  short-term  and  long-term  risk  to  insectivorous  birds.    Further 
information on the background levels of eugenol in the environment might be useful for this purpose.  
A high acute risk for small herbivorous mammals was identified with the first tier assessment of both 
European Commission (2002a) and EFSA (2009) guidance. This assessment was carried out with the 
toxicity endpoint of the formulated product „Mevalone 3AEY‟ i.e LD50 >2000 mg product /kg bw per 
day. In the addendum from June 2012, the combined toxicity of the 3 active substances in the product 
was calculated using the Finney equation. The predicted toxicity to mammals exposed to the active 
substances in combination was lower than that indicated by the acute study for the product. As a 
consequence, the TER calculated with the estimated theoretical exposure for the formulation was 
above the trigger, indicating a low acute risk to small herbivorous mammals. The long-term risk to 
mammals was indicated as low with the first tier assessment.  
The acute risk assessment for fish and aquatic invertebrates and the risk assessment for algae were 
performed with FOCUS step 1 and 2 PECsw values which were calculated assuming a Koc value of 
10mL/g. The risk was indicated as low for fish and algae, but the TER for Daphnia was below the 
trigger.  No  chronic  studies  were  available  on  fish  and  Daphnia,  and  no  data  were  available  on 
sediment-dwelling organisms. Overall, a data gap was identified to further consider the risk to aquatic 
organisms.  Further information on the background levels of eugenol in the environment might be 
useful for this purpose.  
The risk to honeybees was indicated as low by the HQ values calculated on the basis of oral and 
contact toxicity data on Apis mellifera with the formulation. 
The  in-field  and  off-field  risk  to  non-target  arthropods  was  indicated  as  low  by  the  HQ  values 
calculated for the standard species Typhlodromus pyri and Aphidius rhopalosiphi.  
The acute risk to earthworms was indicated as low by the acute TER value. 
The risk to soil microorganisms, terrestrial non-target plants and methods for sewage treatment plants 
was considered as low. 
 Peer review of the pesticide risk assessment of the active substance eugenol 
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6.  Overview of the risk assessment of compounds listed in residue definitions triggering assessment of effects data for the environmental 
compartments 
6.1.  Soil 
Compound 
(name and/or code)  Persistence  Ecotoxicology 
eugenol 
DT50 = 30 d (Default according REACH guidance for 
readily  biodegradable  substances  with  a  Kd  <  100 
mL/g) 
Risk to earthworms assessed as low.  
Data gap identified for a soil degradation study where 
relevant metabolite methyleugenol is accounted for.  -  - 
6.2.  Groundwater 
Compound 
(name and/or code)  Mobility in soil 
>0.1  μg/L  1m  depth  for 
the  representative  uses 
(at  least  one  FOCUS 
scenario  or  relevant 
lysimeter) 
Pesticidal activity  Toxicological relevance  Ecotoxicological activity 
eugenol 
No  data,  data  gap 
identified. 
Koc  =  10  mL/g  used  for 
the  groundwater  risk 
assessment in the absence 
of experimental data. 
FOCUS  GW:  Yes,  0.1 
µg/L  is  exceeded  in  9/9 
scenarios  
Yes  Yes 
Yes.  
Data  gap  to  further 
address the risk to aquatic 
organisms.  
Data gap identified for a 
soil degradation study 
where relevant metabolite 
methyleugenol is 
accounted for. 
-  -  -  Yes,  methyleugenol  is  a 
genotoxic carcinogen  No data Peer review of the pesticide risk assessment of the active substance eugenol 
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6.3.  Surface water and sediment 
Compound 
(name and/or code)  Ecotoxicology 
eugenol  Data gap to further address the risk to aquatic organisms. 
Data gap identified for a soil degradation study where 
relevant metabolite methyleugenol is accounted for.   No data 
6.4.  Air 
Compound 
(name and/or code)  Toxicology 
eugenol  Rat LC50 > 2.58 mg/L 
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7.  List of studies to be generated, still ongoing or available but not peer reviewed 
This is a complete list of the data gaps identified during the peer review process, including those areas 
where a study may have been made available during the peer review process but not considered for 
procedural  reasons  (without  prejudice  to  the  provisions  of  Article  7  of  Directive  91/414/EEC 
concerning information on potentially harmful effects). 
  Address the levels of methyleugenol in the formulation as they are higher than the calculated value 
from the technical material specification (relevant for all representative uses evaluated; submission 
date proposed by the applicant: unknown; see section 1). 
  Methods  of  analysis  for  soil,  water  and  air  (relevant  for  all  representative  uses  evaluated; 
submission date proposed by the applicant: unknown; see section 1). 
  Further toxicological assessment of methyleugenol in order to allow for the determination of an 
acceptable level in the technical specification and reference values are required in order to conduct 
the human health risk assessment (relevant for the  representative uses evaluated; submission date 
proposed by the applicant: unknown; see section 2, 3 and 4). 
  Storage stability data to cover the maximum storage time interval of eugenol in samples from the 
residue  trials  (relevant  for  the  representative  use  evaluated;  submission  date  proposed  by  the 
applicant: unknown; see section 3). 
  Relevant  data  to  determine  the  occurrence  of  methyleugenol  as  a  residue  in  grapes  with  a 
sufficiently low limit of quantification when the formulated product is applied in accordance with 
the representative use (relevant for the representative use evaluated; submission date proposed by 
the applicant: unknown; see section 3). 
  A  soil  incubation  with  eugenol  under  aerobic  conditions  is  required  where  methyleugenol  is 
analysed for (both in soil and volatile traps), with an appropriate low limit of quantification that is 
significantly below 5% of the dosed concentration in soil (relevant for all representative uses 
evaluated; submission date proposed by the applicant: unknown; see section 4). 
  Rate of degradation study of eugenol in four different soils under aerobic conditions is needed to 
refine  the  soil  and  groundwater  exposure  assessment  (relevant  for  all  representative  uses 
evaluated; submission date proposed by the applicant: unknown; see section 4). 
  Information to address the potential for photolysis in soil (relevant for  all representative uses 
evaluated; submission date proposed by the applicant: unknown; see section 4). 
  A batch soil adsorption/desorption study is required on 4 soils. Soils should cover the range of pH 
and organic carbon content defined in the data requirements (relevant for all representative uses 
evaluated; submission date proposed by the applicant: unknown; see section 4). 
  A  study  to  address  the  potential  for  photolysis  in  water  (relevant  for  all  representative  uses 
evaluated; submission date proposed by the applicant: unknown; see section 4). 
  Information to address the short-term and long-term risk to insectivorous birds (relevant for all 
representative uses evaluated; submission date proposed by the applicant: unknown; see section 
5). 
  Information to address the risk to aquatic organisms (relevant for all representative uses evaluated; 
submission date proposed by the applicant: unknown; see section 5). Peer review of the pesticide risk assessment of the active substance eugenol 
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8.  Particular conditions proposed to be taken into account to manage the risk(s) identified 
none 
9.  Concerns 
9.1.  Issues that could not be finalised 
An  issue  is  listed  as  an  issue  that  could  not  be  finalised  where  there  is  not  enough  information 
available to perform an assessment, even at the lowest tier level, for the representative uses in line 
with the Uniform Principles of Annex VI to Directive 91/414/EEC and where the issue is of such 
importance that it could, when finalised, become a concern (which would also be listed as a critical 
area of concern if it is of relevance to all representative uses). 
1.  The environmental risk assessment, including the groundwater exposure assessment, cannot be 
concluded  for  potential  metabolites  of  eugenol  (in  particular  for  the  impurity  and  potential 
metabolite methyleugenol) due to the lack of information on the route of degradation of eugenol 
in soil.   
2.  The short-term and long-term risk assessment for insectivorous birds could not be finalised on the 
basis of the available data. 
9.2.  Critical areas of concern 
An issue is listed as a critical area of concern where there is enough information available to perform 
an assessment for the representative uses in line with the Uniform Principles of Annex VI to Directive 
91/414/EEC,  and  where  this  assessment  does  not  permit  to  conclude  that  for  at  least  one  of  the 
representative uses it may be expected that a plant protection product containing the active substance 
will not have any harmful effect on human or animal health or on groundwater or any unacceptable 
influence on the environment.   
An issue is also listed as a critical area of concern where the assessment at a higher tier level could not 
be finalised due to a lack of information, and where the assessment performed at the lower tier level 
does not permit to conclude that for at least one of the representative uses it may be expected that a 
plant protection product containing the active substance will not have any harmful effect on human or 
animal health or on groundwater or any unacceptable influence on the environment. 
3.  The technical material and formulated product contain the impurity methyleugenol, which is a 
genotoxic carcinogen. No reference values or acceptable level can be derived and the human 
health risk assessment cannot be conducted. 
4.  When assessed on the basis of the available data, a high potential for groundwater exposure by 
eugenol above the parametric drinking water limit of 0.1 µg/L is predicted over a wide range of 
geoclimatic conditions (limit of 0.1 µg/L is exceeded by eugenol in nine of the nine groundwater 
scenarios simulated for the representative use proposed). 
5.  A high risk to aquatic organisms was identified on the basis of the available data. 
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9.3.  Overview of the concerns identified for each representative use considered 
(If a particular condition proposed to be taken into account to manage an identified risk, as listed in 
section 8, has been evaluated as being effective, then „risk identified‟ is not indicated in this table.) 
The  technical  material  and  formulated  product  contain  the  impurity  methyleugenol  which  is  a 
genotoxic carcinogen. No reference values or acceptable level can be derived and the human health 
risk assessment cannot be conducted 
Representative use  Table and wine grapes 
Operator risk 
Risk identified   
Assessment not finalised  X
3 
Worker risk 
Risk identified   
Assessment not finalised  X
3 
Bystander risk 
Risk identified   
Assessment not finalised  X
3 
Consumer risk 
Risk identified   
Assessment not finalised  X
3 
Risk to wild non 
target terrestrial 
vertebrates 
Risk identified   
Assessment not finalised  X
2 
Risk to wild non 
target terrestrial 
organisms other 
than vertebrates 
Risk identified   
Assessment not finalised   
Risk to aquatic 
organisms 
Risk identified  X
5 
Assessment not finalised   
Groundwater 
exposure active 
substance 
Legal parametric value 
breached  X
4 
Assessment not finalised   
Groundwater 
exposure 
metabolites 
Legal parametric value 
breached   
Parametric value of 
10µg/L
(a) breached   
Assessment not finalised  X
1 
Comments/Remarks   
The superscript numbers in this table relate to the numbered points indicated in sections 9.1 and 9.2.  Where there is no 
superscript number see sections 2 to 6 for further information. 
(a):  Value for non-relevant metabolites prescribed in SANCO/221/2000-rev 10-final, European Commission, 2003 Peer review of the pesticide risk assessment of the active substance eugenol 
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APPENDICES 
APPENDIX A – LIST  OF  END  POINTS  FOR  THE  ACTIVE  SUBSTANCE  AND  THE  REPRESENTATIVE 
FORMULATION 
Identity, Physical and Chemical Properties, Details of Uses, Further Information  
 
Active substance (ISO Common Name) ‡  Eugenol (No ISO common name) 
Function (e.g. fungicide)  Fungicide 
 
Rapporteur Member State  UK 
Co-rapporteur Member State  N/A 
 
Identity (Annex IIA, point 1) 
Chemical name (IUPAC) ‡  4-allyl-2-methoxyphenol 
Chemical name (CA) ‡  2-methoxy-4-(2-propenyl)phenol 
CIPAC No  ‡  Not assigned 
CAS No  ‡  97-53-0 
EC No (EINECS or ELINCS) ‡  Not assigned 
FAO Specification (including year of 
publication) ‡ 
None 
Minimum purity of the active substance as 
manufactured  ‡ 
990 g/kg 
Identity of relevant impurities (of 
toxicological, ecotoxicological and/or 
environmental concern) in the active substance 
as manufactured 
Methyleugenol; max 0.005% w/w (0.05 g/kg) 
Molecular formula ‡  C10H12O2 
Molecular mass ‡  164.20 g/mol 
Structural formula ‡ 
CH2
OCH3
OH
 Peer review of the pesticide risk assessment of the active substance eugenol 
 
EFSA Journal 2012;10(11):2914    18 
Physical and chemical properties (Annex IIA, point 2) 
 
Melting point (state purity) ‡  <-40°C (98.8%) 
Boiling point (state purity) ‡  254.7 °C (98.8%) 
Temperature of decomposition (state purity)   No data 
Appearance (state purity) ‡  Pale straw coloured oily liquid with strong clove oil 
odour (98.8%) 
Vapour pressure (state temperature, state 
purity) ‡ 
2.7 Pa at 20°C (98.8%.) 
Henry‟s law constant ‡  0.24Pa m
3 mol 
-1 
Solubility in water (state temperature, state 
purity and pH) ‡ 
1.95 mg /L at 20°C (pH 4) (98.8%) 
1.85 mg /L at 20°C (pH 7) (98.8%) 
2.35 mg /L at 20°C (pH 10) (98.8%) 
Solubility in organic solvents ‡ 
(state temperature, state purity)  
Solubility at 20°C in g/L (98.8%) was >250 g/l in 
n-heptane; p-xylene; 1,2-dichlorethane; methanol; 
acetone and ethyl acetate. 
Surface tension ‡ 
(state concentration and temperature, state 
purity) 
41.2 mN/m at 20°C (90 % saturated solution) 
(98.8%) 
Partition co-efficient ‡ 
(state temperature, pH and purity) 
log PO/W  =  2.30 at 21.5°C (98.8%) 1:1 o:w 
log PO/W  =  2.43 at 21.5°C (98.8%) 2:1 o:w 
log PO/W  =  2.45 at 21.5°C (98.8%) 1:2 o:w 
Effect of pH not recorded, pH of test medium not 
reported. 
Dissociation constant (state purity) ‡  pKa1 =   10.27(98.8%) 
UV/VIS absorption (max.) incl.   ‡  
(state purity, pH) 
98.8% purity 
pH 1.92 
λmax                              ε 
201 nm           37988 
222 nm             6566 
281 nm            2883 
 
pH 7.01 
λmax                              ε 
200 nm            39846 
226 nm             6374 
281 nm             2883 
 
pH 11.6 
λmax                              ε 
206 nm           30461 
246 nm             7816 
297 nm             3780 
Flammability ‡ (state purity)  Flash point = 127°C (98.8%) 
Explosive properties ‡ (state purity)  Not explosive (98.8%) Peer review of the pesticide risk assessment of the active substance eugenol 
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Oxidising properties ‡ (state purity)  Not oxidising (98.8%) 
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Summary of representative uses evaluated (eugenol)* 
 
Crop and/ 
or situation 
 
 
Member 
State 
or 
Country 
Product 
name 
F 
G 
or 
I 
 
Pests or 
Group of 
pests 
controlled 
 
 
Preparation 
 
Application 
Application rate per 
treatment 
PHI 
(days) 
 
 
Remarks 
 
 
(a) 
     
(b) 
 
(c) 
Type 
 
(d-f) 
Conc. 
of as 
 
(i) 
method 
kind 
 
(f-h) 
growth 
stage & season 
 
(j) 
number 
min/ 
max 
 
(k) 
interval 
between 
applications 
(min) 
kg as/hL  
 
min – 
max 
(l) 
water 
L/ha 
 
min – 
max 
kg as/ha 
 
min – 
max 
(l) 
 
(m) 
 
 
Table and 
wine grapes 
Greece  Mevalone 
3AEY 
F  Botrytis  CS  3.2% 
(E) 
6.4% 
(G) 
6.4% 
(T) 
High 
volume 
spraying, 
Broadcast 
BBCH 60-89  1 - 4  7 days  0.013 
(E) 
0.026 
(G) 
0.026 
(T) 
400 - 
1000 
0.05 - 
0.13 (E) 
0.10 - 
0.26 
(G) 
0.10 - 
0.26 (T) 
7 days  Preventative and 
curative control 
 
 
  For  uses  where  the  column  "Remarks"  is  marked  in  grey  further  consideration  is  necessary.  
Uses should be crossed out when the notifier no longer supports this use(s). 
(a)  For crops, the EU and Codex classifications (both) should be taken into account; where relevant, the use 
situation should be described (e.g. fumigation of a structure) 
(b) Outdoor or field use (F), greenhouse application (G) or indoor application (I) 
(c)  e.g. biting and suckling insects, soil born insects, foliar fungi, weeds 
(d) e.g. wettable powder (WP), emulsifiable concentrate (EC), granule (GR) 
(e)  GCPF Codes - GIFAP Technical Monograph No 2, 1989 
(f)  All abbreviations used must be explained 
(g) Method, e.g. high volume spraying, low volume spraying, spreading, dusting, drench 
(h) Kind, e.g. overall, broadcast, aerial spraying, row, individual plant, between the plant- type of equipment 
used must be indicated 
(i)  g/kg or g/L. Normally the rate should be given for the active substance (according to ISO) and not for 
the variant in order to compare the rate for same active substances used in different variants (e.g. 
fluoroxypyr). In certain cases, where only one variant is synthesised, it is more appropriate to give 
the rate for the variant (e.g. benthiavalicarb-isopropyl). 
(j)  Growth stage at last treatment (BBCH Monograph, Growth Stages of Plants, 1997, Blackwell, ISBN 3-
8263-3152-4), including where relevant, information on season at time of application 
(k)  Indicate the minimum and maximum number of application possible under practical conditions of use 
(l)  The values should be given in g or kg whatever gives the more manageable number (e.g. 200 kg/ha 
instead of 200 000 g/ha or 12.5 g/ha instead of 0.0125 kg/ha 
(m)  PHI - minimum pre-harvest interval 
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Methods of Analysis 
Analytical methods for the active substance (Annex IIA, point 4.1) 
Technical as (analytical technique)  Eugenol determined by GC-FID with Solgel-wax 
capillary column 
Impurities in technical as (analytical 
technique) 
Impurities determined by GC-FID with Solgel-wax 
capillary column 
Plant protection product (analytical technique)  Eugenol determined by GC-FID with Zebron ZB-5 
capillary column 
 
Analytical methods for residues (Annex IIA, point 4.2) 
Residue definitions for monitoring purposes 
Food of plant origin  Currently not required (see section 3) 
Food of animal origin  Not required 
Soil  Eugenol, open for other compounds. 
Water   surface   Eugenol, open for other compounds. 
  drinking/ground   Eugenol, open for other compounds. 
Air  Eugenol, open for other compounds. 
 
Monitoring/Enforcement methods 
Food/feed of plant origin (analytical technique 
and LOQ for methods for monitoring 
purposes) 
Not required. 
Food/feed of animal origin (analytical 
technique and LOQ for methods for 
monitoring purposes) 
Not required 
Soil (analytical technique and LOQ)  Open 
Water (analytical technique and LOQ)  Open 
Air (analytical technique and LOQ)  Open 
Body fluids and tissues (analytical technique 
and LOQ) 
Not required as the active substance is not classified 
as toxic or very toxic. 
 
Classification and proposed labelling with regard to physical and chemical data (Annex IIA, 
point 10) 
  RMS/peer review proposal  
Active substance   None 
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Impact on Human and Animal Health 
Absorption, distribution, excretion and metabolism (toxicokinetics) (Annex IIA, point 5.1) 
Rate and extent of oral absorption ‡  Rapid (>70 % excreted within 3h) and extensive 
(>90 % in urine within 24h) – humans, 2 mg/kg bw 
Distribution ‡  No data available 
Potential for accumulation ‡  Accumulation is unlikely based on rapid and 
extensive excretion 
Rate and extent of excretion ‡  Rapid and extensive (>90% in urine within 
24 hours) 
Metabolism in animals ‡  Glucuronide and sulphate conjugates are the major 
pathways.  Metabolism to polar metabolites also 
occurs. 
Toxicologically relevant compounds ‡ 
(animals and plants) 
Eugenol, methyleugenol 
Toxicologically relevant compounds ‡ 
(environment) 
Eugenol, methyleugenol 
 
 
Acute toxicity (Annex IIA, point 5.2) 
Rat LD50 oral ‡  1930 mg/kg bw (rat) 
≈500 mg/kg bw (dog) 
R22 
Rat LD50 dermal ‡  No data available – not required   
Rat LC50 inhalation ‡  >2.58 mg/L   
Skin irritation ‡  Irritant  R38 
Eye irritation ‡  No data available, considered eye irritant 
based on skin irritation potential 
R36 
Skin sensitisation ‡  Sensitising (Maximisation test with guinea 
pigs, Local Lymph Node Assay with mice, 
human reports) 
R43 
 
Short term toxicity (Annex IIA, point 5.3) 
Target / critical effect ‡  Reduced bodyweight gains (rat) 
Relevant oral NOAEL ‡  Rat:  600 mg/kg bw per day (13-wk) 
Dog:  100 mg/kg bw per day (highest dose 
tested, 10 administrations) 
Mouse: 900 mg/kg bw per day (13-wk) 
 
Relevant dermal NOAEL ‡  No data available   
Relevant inhalation NOAEL ‡  No data available   
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Genotoxicity ‡ (Annex IIA, point 5.4) 
  Positive at cytotoxic concentrations in vitro 
(gene  mutation,  DNA  adducts  and 
chromosomal  aberrations  in  mammalian 
cells)  and  at  very  high  doses  in  vivo 
(micronucleus).  
Unlikely to be genotoxic at exposures that 
do not result in cytotoxicity and saturation 
of conjugation pathways. 
 
 
Long term toxicity and carcinogenicity (Annex IIA, point 5.5) 
Target/critical effect ‡  Reduced bodyweights, spleen haemosiderosis, 
uterine cystic hyperplasia (rat) 
Reduced bodyweights and food consumption, 
inflammation in lungs and kidneys (mice) 
Relevant NOAEL ‡  Rat:  300 mg/kg bw per day 
Mouse:  450 mg/kg bw per day 
Carcinogenicity ‡  No carcinogenic potential for humans   
 
Reproductive toxicity (Annex IIA, point 5.6) 
Reproduction toxicity 
Reproduction target / critical effect ‡  No data available   
Relevant parental NOAEL ‡  No data available   
Relevant reproductive NOAEL ‡  No data available   
Relevant offspring NOAEL ‡  No data available   
 
Developmental toxicity  
Developmental target / critical effect ‡  Developmental:   foetal weight and 
delayed ossification (rat), increased post-
implantation loss (rabbit)  
Maternal: clinical signs (rat, rabbit) and 
reduced food consumption (rabbit) 
 
Relevant maternal NOAEL ‡  100 mg/kg bw per day (rat, rabbit)   
Relevant developmental NOAEL ‡  250 mg/kg bw per day (rat, rabbit)   
 
Neurotoxicity (Annex IIA, point 5.7) 
Acute neurotoxicity ‡  No specific study – no indications of a 
neurotoxic potential in the available 
database  
 
Repeated neurotoxicity ‡  No indications in the available studies.    
Delayed neurotoxicity ‡  No indications in the available studies.    Peer review of the pesticide risk assessment of the active substance eugenol 
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Other toxicological studies (Annex IIA, point 5.8) 
Mechanism studies ‡  Glutathione pre-cursors provide protection against 
cytotoxicity in vitro 
Studies performed on metabolites or impurities 
‡ 
 
Limited data available (published literature) for the 
impurities, indicating no toxicological concern, 
except for methyleugenol, considered as genotoxic 
and carcinogenic 
 
Medical data ‡ (Annex IIA, point 5.9) 
  Reports of skin irritation and skin sensitisation in 
humans. 
 
Summary (Annex IIA, point 5.10)  Value  Study  Safety 
factor 
ADI ‡  1.0 mg/kg bw per 
day 
Rat & rabbit 
developmental 
100 
AOEL ‡  1.0 mg/kg bw per 
day 
Rat and rabbit 
developmental 
100 
ARfD ‡  Not necessary    - 
 
Dermal absorption ‡ (Annex IIIA, point 7.3) 
Formulation 
„Mevalone 3AEY‟ 
Capsule suspension (CS) containing 
3.2% eugenol, 6.4% geraniol and 6.4% thymol 
No data.  Default value of 100% assumed. 
 
Exposure scenarios (Annex IIIA, point 7.2)  
Operator  Assessment for eugenol: 
Vehicle mounted sprayers 
German model – no PPE: 21% of AOEL,  
UK POEM – no PPE: 43% of AOEL,   
EUROPOEM – no PPE: 33% of AOEL. 
Hand-held sprayers 
German model – no PPE: 46% of AOEL,  
UK POEM – no PPE: 97% of AOEL. 
Assessment for methyleugenol: 
Cannot be conducted since no acceptable level can 
be established on the basis of the data available. Peer review of the pesticide risk assessment of the active substance eugenol 
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Workers  Assessment for eugenol: 
Re-entry exposure for harvest workers: 
24% after 1 treatment, 
96% after 4 treatments assuming no dissipation. 
Assessment for methyleugenol: 
Cannot be conducted since no acceptable level can 
be established on the basis of the data available. 
Bystanders  Assessment for eugenol: 
Exposure to drift during application: 1% of AOEL,  
Exposure to drift fallout: <1% of AOEL,  
Exposure to volatilised pesticide (post application): 
<1 % of AOEL.  
Assessment for methyleugenol: 
Cannot be conducted since no acceptable level can 
be established on the basis of the data available. 
 
Classification and proposed labelling with regard to toxicological data (Annex IIA, point 10) 
  RMS/peer review proposal 
according to Directive 67/548/EEC 
RMS/peer review proposal 
according to CLP 
Regulation 1272/2008 
Eugenol  R22 – Harmful if swallowed 
R36 – Irritating to eyes 
R38 – Irritating to skin 
R43 – May cause sensitisation by 
skin contact 
Acute Tox. 4; H302 
Skin Irrit. 2; H315 
Eye Irrit. 2; H319 
Skin Sens. 1; H317 
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Metabolism in plants (Annex IIA, point 6.1 and 6.7, Annex IIIA, point 8.1 and 8.6) 
The overall consumer risk assessment with regard to methyleugenol could not be concluded on the 
basis of the available data and in the absence of an acceptable toxicological level. 
Plant groups covered  Currently not required 
(1) 
Rotational crops  Data not required. 
Metabolism in rotational crops similar to 
metabolism in primary crops? 
N/A 
Processed commodities  Data not required 
Residue pattern in processed commodities 
similar to residue pattern in raw commodities? 
N/A 
Plant residue definition for monitoring  Not required
(1). 
Plant residue definition for risk assessment  Not required
(1). 
Conversion factor (monitoring to risk 
assessment) 
N/A 
(1): Additional metabolism data and residue definitions not required pending the acceptability of the 
residue trials. 
 
Metabolism in livestock (Annex IIA, point 6.2 and 6.7, Annex IIIA, point 8.1 and 8.6) 
Animals covered  Data not required. 
Time needed to reach a plateau concentration 
in milk and eggs 
N/A 
Animal residue definition for monitoring  Not required. 
Animal residue definition for risk assessment  Not required. 
Conversion factor (monitoring to risk 
assessment) 
N/A 
Metabolism in rat and ruminant similar 
(yes/no) 
N/A 
Fat soluble residue: (yes/no)  N/A 
 
 
Residues in succeeding crops (Annex IIA, point 6.6, Annex IIIA, point 8.5) 
  Not required. 
 
Stability of residues (Annex IIA, point 6 introduction, Annex IIIA, point 8 Introduction) 
  No conclusion can be drawn based on the reported 
studies in the Addendum to the DAR (June 2012) 
Data gap for new storage stability data on eugenol 
residues. 
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Residues from livestock feeding studies (Annex IIA, point 6.4, Annex IIIA, point 8.3) 
  Ruminant:   Poultry:
   Pig:
  
  Conditions of requirement of feeding studies 
Expected intakes by livestock   0.1 mg/kg diet 
(dry weight basis) (yes/no - If yes, specify the 
level) 
N/A  N/A  N/A 
Potential for accumulation (yes/no):  N/A  N/A  N/A 
Metabolism studies indicate potential level of 
residues ≥ 0.01 mg/kg in edible tissues (yes/no) 
N/A  N/A  N/A 
  Feeding studies (Specify the feeding rate in cattle 
and poultry studies considered as relevant) 
Residue levels in matrices : Mean (max) mg/kg 
Muscle  N/A  N/A  N/A 
Liver  N/A  N/A  N/A 
Kidney  N/A  N/A  N/A 
Fat  N/A  N/A  N/A 
Milk  N/A     
Eggs    N/A   
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Summary of residues data according to the representative uses on raw agricultural commodities and feedingstuffs (Annex IIA, point 6.3, Annex 
IIIA, point 8.2) 
Crop  Northern or 
Mediterranean Region, 
field or glasshouse, and 
any other useful 
information 
Trials results relevant to the 
representative uses 
 
(a) 
Recommendation/comments  MRL estimated 
from trials 
according to the 
representative use 
HR 
 
(c) 
STMR 
 
(b) 
Table & 
wine grapes 
Southern/ Mediterranean  
EU 
 4 x < 0.05
(2),   4  available  residue  trials  to 
determine eugenol residue levels 
conducted  at  2N  rate-Residue 
values  below  the  LOQ  (<  0.05 
gm/kg). 
Open  Open  Open 
(2): Acceptability of the residue trials on eugenol pending the outcome of the requested storage stability data. 
 
(a) Numbers of trials in which particular residue levels were reported e.g. 3 x <0.01, 1 x 0.01, 6 x 0.02, 1 x 0.04, 1 x 0.08, 2 x 0.1, 2 x 0.15, 1 x 0.17 
(b) Supervised Trials Median Residue i.e. the median residue level estimated on the basis of supervised trials relating to the representative use 
(c) Highest residue 
 Peer review of the pesticide risk assessment of the active substance eugenol 
 
EFSA Journal 2012;10(11):2914    29 
Consumer risk assessment (Annex IIA, point 6.9, Annex IIIA, point 8.8) 
Provisional consumer risk assessment performed with regard to eugenol residues pending the 
acceptability of the residue trials. 
ADI   1 mg/kg bw per day 
TMDI (% ADI) according to EFSA PRIMo 
Model rev.2A 
<0.1% ADI (Provisional) 
TMDI (% ADI) according to national (to be 
specified) diets 
N/A 
IEDI (WHO European Diet) (% ADI)  N/A 
NEDI (specify diet) (% ADI)  N/A 
Factors included in IEDI and NEDI  N/A 
ARfD  Not allocated 
IESTI (% ARfD) according to EFSA PRIMo 
Model rev.2A 
N/A 
NESTI (% ARfD) according to national (to be 
specified) large portion consumption data 
N/A 
Factors included in IESTI and NESTI   N/A 
 
Processing factors (Annex IIA, point 6.5, Annex IIIA, point 8.4) 
Crop/ process/ processed product 
 
Number of 
studies 
Processing factors  Amount 
transferred (%) 
(Optional) 
Transfer 
factor  
Yield 
factor  
Not required         
 
Proposed MRLs (Annex IIA, point 6.7, Annex IIIA, point 8.6) 
 
  Open 
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Route of degradation (aerobic) in soil (Annex IIA, point 7.1.1.1.1) 
Mineralization after 100 days ‡ 
 
No data submitted 
Non-extractable residues after 100 days ‡ 
 
No data submitted 
Metabolites requiring further consideration ‡ 
- name and/or code, % of applied (range and 
maximum) 
No data submitted. Data gap to address the potential 
formation of methyleugenol in soil. 
 
 
Route of degradation in soil - Supplemental studies (Annex IIA, point 7.1.1.1.2) 
Anaerobic degradation ‡ 
Mineralization after 100 days 
 
No data submitted 
Non-extractable residues after 100 days 
 
No data submitted 
Metabolites that may require further 
consideration for risk assessment - name 
and/or code, % of applied (range and 
maximum) 
No data submitted 
Soil photolysis ‡ 
Metabolites that may require further 
consideration for risk assessment - name 
and/or code, % of applied (range and 
maximum) 
No data submitted. Data gap identified for a 
photolysis study of eugenol in soil. 
Rate of degradation in soil (Annex IIA, point 7.1.1.2, Annex IIIA, point 9.1.1) 
Laboratory studies ‡ 
Parent  Aerobic conditions:  No data submitted.  Non-standard study on rate of release of 
eugenol from formulation „Mevalone 3AEY‟ on dry filter, 40% eugenol still 
retained in formulation after 3 days.  Under dry – wet – dry conditions (dry 
formulation wetted every 24 hours), 98% release achieved within four days, 2% 
remaining at 4 days. 
Data gap identified for rate of degradation of eugenol under aerobic conditions in 
four soils.   
 
Field studies: No data submitted 
 
Laboratory studies ‡ 
Parent  Anaerobic conditions. No data submitted 
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Soil adsorption/desorption (Annex IIA, point 7.1.2) 
Parent  ‡ No laboratory data submitted. Data gap identified for batch adsorption / desorption studies in 
four soils. 
 
Mobility in soil (Annex IIA, point 7.1.3, Annex IIIA, point 9.1.2) 
Column leaching ‡  No data submitted 
Aged residues leaching ‡  No data submitted 
 
Lysimeter/ field leaching studies ‡  No data submitted 
 
PEC (soil) (Annex IIIA, point 9.1.3) 
Parent 
Method of calculation 
DT50 (d): 30 days (default from ECHA guidance) 
Kinetics: SFO 
Field or Lab: Not applicable. 
Application data  Crop: grapes 
Depth of soil layer: 5cm  
Soil bulk density: 1.5g/cm
3 
% plant interception: 70% 
Number of applications: 4 
Interval (d): 7 days 
Application rate(s): 132.8 g as/ha  
DT50: 30 days 
 
PEC(s) 
(mg/kg) 
Single  
application 
Actual 
Single 
application 
Time weighted 
average 
Multiple  
application 
Actual 
Multiple  
application 
Time weighted 
average 
Initial  0.053    0.169   
Short term 24h  0.052  0.053  0.165  0.167 
  2d  0.051  0.052  0.161  0.165 
  4d  0.048  0.051  0.154  0.162 
Long term 7d  0.045  0.049  0.144  0.156 
  14d  0.038  0.045  0.122  0.144 
  28d  0.028  0.039  0.089  0.125 
  50d  0.017  0.031  0.053  0.100 
  100d  0.005  0.021  0.017  0.066 
Plateau 
concentration  Not applicable 
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Route and rate of degradation in water (Annex IIA, point 7.2.1) 
Hydrolytic degradation of the active substance 
and metabolites > 10 % ‡ 
No data submitted. Considered to be stable at pH 5- 
pH 9 based on chemical structure.  
Photolytic degradation of active substance and 
metabolites above 10 % ‡ 
No data submitted. Data gap identified. 
Quantum yield of direct phototransformation 
in water at   > 290 nm 
No data submitted 
Readily biodegradable ‡  
(yes/no) 
Yes 
 
Degradation in water / sediment 
Parent  No data submitted on fate in natural water.  Non-standard study on rate of release of 
eugenol from formulation „Mevalone 3AEY‟ under continuous wet conditions (tap 
water), DT50 of gas phase concentration 3.2 days, 91% release of eugenol in 7 days. 
 
PEC (surface water) and PEC sediment (Annex IIIA, point 9.2.3) 
Parent 
FOCUSsw Steps 1-2 methodology 
Note crop used is late vines due to highest spray 
drift values.  Highest PEC values result for multiple 
applications, PEC values from single applications 
not shown. 
Application rate  Crop: Vines (late) 
Crop interception: Full canopy 
Number of applications: 4 
Interval (d): 7 
Application rate(s): 132.8 g as/ha 
Application window: Not applicable 
Molecular weight: 164.20 
Water solubility: 2.350 mg/l 
DT50 soil:  30 days (default REACH ECHA 2010) 
DT50 water:  15 days (default REACH ECHA 2010) 
DT50 sediment:  300 days (default REACH ECHA 
2010) 
Koc:  10 ml/g or 10000 ml/g 
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PECsw 
 
Time 
(d) 
Eugenol PECsw (µg/L).  Note Koc = 10 ml/g 
Step-1   
Step-2: 
Southern 
Europe 
March/May 
Step-2: 
Southern 
Europe 
June/September 
Step-2: 
Northern 
Europe 
March/May 
Step-2: 
Northern 
Europe 
June/September 
Actual    Actual    Actual    Actual    Actual   
Initial  188.95    21.62    17.81    14.00    14.00   
Day  0  25  25  25  25 
With low Koc, peak PECsw at Step 2 is as a result of the drainage/run-off event 
 
PECsed 
 
Time 
(d) 
Eugenol PECsed (µg/kg).  Note Koc = 10000 ml/g 
Step-1 
Step-2: 
Southern 
Europe 
March/May 
Step-2: 
Southern 
Europe 
June/September 
Step-2: 
Northern 
Europe 
March/May 
Step-2: 
Northern 
Europe 
June/September 
Actual    Actual    Actual    Actual    Actual   
Initial  1330    180.63    153.75    126.86    126.86   
Day  0  26  26  26  26 
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PEC (groundwater) (Annex IIIA, point 9.2.1) 
Method of calculation and type of study (e.g. 
modelling, field leaching, lysimeter ) 
FOCUSgw methodology.  FOCUS_PEARL 4.4.4. 
Molecular weight:  164.20 
Water solubility:  2350 mg/l at 20°C 
Vapour pressure:  2.7 Pa at 20°C 
DT50 soil: 30 days (default REACH ECHA 2010) 
Q10: 2.58 
Kfoc:  10 / 1124 ml/g 
Kfom:  5.8 / 652 ml/g 
1/n:  0.9 
Crop uptake factor: 0.5 
  Gap details: 
Modelling with Koc 10 ml/g 
Vines, 4 x 132.8 g/ha, 70% interception, 
applications 15/4, 22/4, 29/4, 6/5 
 
Modelling with Koc 1124 ml/g 
Same GAP but applications made 15/4, 5/6, 26/7, 
15/9 
Results (µg/l 80
th percentile annual average 
concentration at 1m) 
Modelling with Koc 10 ml/g 
Location 
Eugenol 
(µg/l) 
Chateaudun  4.659605 
Hamburg  5.07327 
Kremsmuenster  4.167761 
Piacenza  1.854342 
Porto  1.450227 
Sevilla  1.697514 
Thiva  1.162342 
 
 
 
Fate and behaviour in air (Annex IIA, point 7.2.2, Annex III, point 9.3) 
Direct photolysis in air ‡  No data submitted 
Quantum yield of direct phototransformation  No data submitted 
Photochemical oxidative degradation in air ‡  DT50 of 0.165 days derived by the Atkinson model. 
OH (12 h) concentration assumed = 1.5 x 10
6/cm
3 
Volatilisation ‡  No data submitted 
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PEC (air) 
Method of calculation  Not calculated 
 
PEC(a) 
Maximum concentration  Not calculated. Eugenol is expected to volatilize 
under natural environmental conditions 
Residues requiring further assessment  
Environmental occurring metabolite requiring 
further assessment by other disciplines 
(toxicology and ecotoxicology). 
Eugenol.  
Open for soil, groundwater and surface water for 
metabolites. 
 
Monitoring data, if available (Annex IIA, point 7.4) 
Soil (indicate location and type of study)  No data submitted 
Surface water (indicate location and type of 
study) 
No data submitted 
Ground water (indicate location and type of 
study) 
No data submitted 
Air (indicate location and type of study)  No data submitted 
 
Points pertinent to the classification and proposed labelling with regard to fate and behaviour 
data  
Not applicable. 
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Effects on terrestrial vertebrates (Annex IIA, point 8.1, Annex IIIA, points 10.1 and 10.3) 
Species  Test substance  Time scale  End point  
(mg/kg 
bw/day) 
End point  
(mg/kg feed) 
Birds ‡ 
Northern bobwhite quail 
Colinus virginianus 
„Mevalone 3AEY‟  Acute  >10,000 
mg prod/kg 
bw 
NA 
Mammals ‡ 
Rat  Eugenol  Acute  1930 
mg a.s./kg 
bw 
NA 
Rat  „Mevalone 3AEY‟  Acute  >2000 
mg prod/kg 
bw 
NA 
Rat  Eugenol  Long-term  250
1 
mg a.s./kg 
bw 
NA 
NA – not available;  
1NOAEL of 250 mg a.s./kg bw per day based on developmental study in the absence of a multi-
generation study. 
 
Toxicity/exposure ratios for terrestrial vertebrates (Annex IIIA, points 10.1 and 10.3) according 
to SANCO/4145/2000 
Application to grapevine of 4 applications at 4L product (4.140 kg product)/ha 
Indicator species/Category²  Time scale  ETE  TER
1  Annex VI Trigger³ 
Tier 1 (Birds) 
Small insectivorous bird  Acute  
„Mevalone 
3AEY‟ 
223.89  >44.66  10 
Tier 1 (Mammals) 
Small herbivorous mammal  Acute 
„Mevalone 
3AEY‟ 
878.79 
mg 
a.s./kg 
bw 
>2.28
1  10 
Small herbivorous mammal  Acute 
(eugenol) 
28.19 
mg 
a.s./kg 
bw 
68.47  10 
Small herbivorous mammal  Long-term 
(eugenol) 
10.03 
mg 
a.s./kg 
bw 
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1Combined toxicity risk assessment, using Finney equation (Finney, 1942) indicates acute TER is 
114.18 and an acute risk to mammals exposed to the active substance components of the formulation 
is unlikely. 
 
Toxicity/exposure ratios for terrestrial vertebrates (Annex IIIA, points 10.1 and 10.3) according 
to EFSA(2009) 
Application to grapevine of 4 applications at 4L product (4.140 kg product)/ha 
Indicator 
species/Category² 
Time scale  DDD  TER
1  Annex VI Trigger³ 
Screening step (Birds) 
Small herbivorous bird  Acute  
„Mevalone 
3AEY‟ 
710  >14  10 
Screening step (Mammals) 
Small  herbivorous 
mammal 
Acute 
„Mevalone 
3AEY‟ 
1016.45 
mg 
formulation/kg 
bw per day 
>1.97
  10 
Small  herbivorous 
mammal 
Acute 
(eugenol) 
32.6 
mg  a.s./kg  bw 
per day 
59.19  10 
Small  herbivorous 
mammal 
Long-term 
(eugenol) 
21.12 
mg  a.s./Kg 
bw/day 
11.84  5 
Tier I (mammals) 
Large herbivorous 
mammal 
Acute 
„Mevalone 
3AEY‟ 
60.36  mg 
formulation/kg 
bw per day 
>33.13  10 
Small herbivorous 
mammal 
Acute 
„Mevalone 
3AEY‟ 
304.79  mg 
formulation/kg 
bw per day 
>6.56
1  10 
Small omnivorous 
mammal 
Acute 
„Mevalone 
3AEY‟ 
38.75  mg 
formulation/kg 
bw per day 
>51.61  10 
1Combined toxicity risk assessment, using Finney equation (Finney, 1942) indicates acute TER is 
329.3 and an acute risk to mammals exposed to the active substance components of the formulation is 
unlikely. 
 
Toxicity data for aquatic species (most sensitive species of each group) (Annex IIA, point 8.2, 
Annex IIIA, point 10.2) 
Group  Test substance  Time-scale 
(Test type) 
End point  Toxicity
1 
(mg/L) 
Laboratory tests ‡ 
Fish 
Oncorhynchus mykiss 
 
eugenol  Acute 
96h semi 
static 
LC50  >10 
(n) Peer review of the pesticide risk assessment of the active substance eugenol 
 
EFSA Journal 2012;10(11):2914    38 
Group  Test substance  Time-scale 
(Test type) 
End point  Toxicity
1 
(mg/L) 
Oncorhynchus mykiss 
 
„Mevalone 
3AEY‟ 
Acute 
96 h semi 
static 
LC50  31.1 (formn.) 
(n) 
Invertebrates 
Daphnia magna.  Eugenol  48 h (static)  EC50  1.11 
(n) 
Daphnia magna.  „Mevalone 
3AEY‟ 
Acute 
48 h (static) 
EC50  35.4 (formn.) 
(n) 
Sediment dwelling organisms 
Not required 
Algae * 
Pseudokirchneriella 
subcapitata 
eugenol  96 h (static)  72 h Biomass: EbC50 
72 h Growth rate: 
ErC50 
72 h Yield EyC50 
10.0 (formn.) 
15.4 (formn.) 
10.8 (formn.) 
(mm) 
Pseudokirchneriella 
subcapitata 
„Mevalone 
3AEY‟ 
96 h (static)  72h Biomass: EbC50 
72 h Growth rate: 
ErC50 
 
72 h Yield  
EyC50 
  
65.2 (formn.) 
100.8
1 
(formn.) 
 
69.0 (formn.) 
 
(n) 
Aquatic macrophyte 
Not required 
* 72 h endpoint for algae used for risk assessment in line with current requirements 
1This endpoint is an extrapolated value, just above the tested range. 
 
Toxicity/exposure ratios for the most sensitive aquatic organisms (Annex IIIA, point 10.2) 
PECs calculated according to SANCO/3268/2001 (1 October 2001) 
Test substance  Organism  Toxicity 
end point 
(mg/L) 
Time 
scale 
PECsw 
mg/L 
TER  Annex VI 
Trigger
1 
Eugenol  Fish   >10  Acute  0.0039  >2564  100 
„Mevalone 
3AEY‟ 
Fish  31.1  Acute  0.11  283  100 
Eugenol  Aquatic 
invertebrates 
1.11  Acute  0.0039  285  100 
„Mevalone 
3AEY‟ 
Aquatic 
invertebrates 
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Test substance  Organism  Toxicity 
end point 
(mg/L) 
Time 
scale 
PECsw 
mg/L 
TER  Annex VI 
Trigger
1 
Eugenol  Algae  10.0  Acute  0.0039  2564  10 
„Mevalone 
3AEY‟ 
Algae  65.2  Acute  0.11  593  10 
 
PECs calculated according to FOCUS Step 1, assuming eugenol Koc = 10 ml/g (May 2012) 
Group  Test 
substance 
Time-scale 
(Test type) 
End 
point 
Toxicity 
(µg/L) 
PECsw 
(max 
Step 1) 
TER  
 
Annex 
VI 
trigger 
Fish 
Oncorhynchus 
mykiss 
 
Eugenol  96  hr  (semi 
static) 
Mortality, 
LC50 
>10000 
(n) 
188.95  >52.9  100 
Aquatic invertebrates 
Daphnia magna  Eugenol  48 h (static)  Mortality, 
EC50 
1110 
(n) 
188.95  5.9  100 
Algae 
Pseudokirchneriella 
subcapitata  
Eugenol  72 h (static)  72 h 
Yield: 
EyC50 
10000 
(mm) 
188.95  52.9  10 
n = nominal; mm= mean measured 
PECs calculated according to FOCUS Step 2, assuming eugenol Koc = 10 ml/g (May 2012) 
Group  Test 
substance 
Time-scale 
(Test type) 
End 
point 
Toxicity 
(µg/L) 
PECsw 
(max 
Step 2) 
TER  
 
Annex 
VI 
trigger 
Fish 
Oncorhynchus 
mykiss 
 
Eugenol  96  hr  (semi 
static) 
Mortality, 
LC50 
>10000 
(n) 
21.62  >463  100 
Aquatic invertebrates 
Daphnia magna  Eugenol  48 h (static)  Mortality, 
EC50 
1110 
(n) 
21.62  51.3  100 
n = nominal 
 
Bioconcentration 
Not required since log Pow of eugenol is < 3 
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Effects on honeybees (Annex IIA, point 8.3.1, Annex IIIA, point 10.4) 
Test substance  Acute oral toxicity 
(LD50 µg/bee) 
Acute contact toxicity 
(LD50 µg/bee) 
„Mevalone 3AEY‟  >224.6 
(formn.) 
>200 
(formn.) 
Field or semi-field tests 
Not required 
 
Hazard quotients for honey bees (Annex IIIA, point 10.4) 
Application to grapevine at maximum individual rate of 4L product (4.140 Kg product)/ha 
Test substance  Route  Hazard quotient  Annex VI 
Trigger 
Preparation   Contact  <21  50 
Preparation   oral  <18  50 
 
Effects on other arthropod species (Annex IIA, point 8.3.2, Annex IIIA, point 10.5) 
Laboratory tests with standard sensitive species 
Species  Test 
Substance 
End point  Effect 
(LR50 g „3AEY‟/ha) 
Typhlodromus pyri ‡  „Mevalone 
3AEY‟ 
Mortality  >12420
1 
Aphidius rhopalosiphi ‡  „Mevalone 
3AEY‟ 
Mortality  >12420
1 
1Endpoints are uncertain due to the expected high volatilisation from the glass plates in these studies 
 
4 applications to grapevine at 4L product (4.140 Kg product)/ha 
Test substance  Species  Effect 
(LR50 g/ha) 
HQ in-field  HQ off-field
 
(3m drift, 
early/late) 
Trigger 
„Mevalone 
3AEY‟ 
Typhlodromus pyri  >12420  <0.9  <0.22/0.06 
 
2 
„Mevalone 
3AEY‟ 
Aphidius rhopalosiphi  >12420  <0.9  <0.22/0.06  2 
 
Further laboratory and extended laboratory studies ‡ 
Not required 
 
Field or semi-field tests 
Not required. 
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Effects on earthworms, other soil macro-organisms and soil micro-organisms (Annex IIA points 
8.4 and 8.5. Annex IIIA, points, 10.6 and 10.7) 
Test organism  Test substance  Time scale  End point 
Earthworms 
Eisenia foetida  „Mevalone 3AEY‟  Acute  LC 50 > 1000 mg 
formulation/kg soil 
Corrected as log Pow of active 
substances > 2 
LC50corr >500 mg 
formulation/kg soil 
Other soil macro-organisms 
Data on other soil macro-organisms not required. 
Soil micro-organisms 
Nitrogen 
mineralisation 
„Mevalone 3AEY‟  56 days  Deviations from the control of 
-9.23% and -3.19% at 5.44 and 
54.4 mg formulation/kg soil 
respectively 
Carbon mineralisation  „Mevalone 3AEY‟  28 days  Deviations from the control of 
-9.3% and -7.1% at 5.44 and 
54.4 mg formulation/kg soil 
respectively 
Field studies 
Not required 
 
Toxicity/exposure ratios for soil organisms 
Grapevine 4 applications at 4L product (4.140 kg product)/ha 
Test organism  Test substance  Time scale  Soil PEC
1  TER  Trigger 
Earthworms 
Eisenia foetida  „Mevalone 
3AEY‟ 
Acute  5.28 mg 
formulation/kg 
soil. 
Immediately 
after the last 
of 4 
applications 
94.7  5 
1The initial PECsoil following the last of 4 applications, assuming no loss between applications. 
 
Effects on non target plants (Annex IIA, point 8.6, Annex IIIA, point 10.8) 
Preliminary screening data 
No effects seen on a range of dicotyledonenous and monocotyledonous non-target plants exposed to 
application rates including 4 x 4 L „Mevalone 3AEY‟/ha and higher.  
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Effects on biological methods for sewage treatment (Annex IIA 8.7)  
Eugenol  In a ready biodegradability test according to OECD 
301F the mean degradation of eugenol was 84% in 28 
days 
„Mevalone 3AEY‟  In a ready biodegradability test according to OECD 
301F the mean degradation of eugenol was 103% in 
28 days 
Eugenol is extremely volatile and is readily biodegradable, one route of dissipation being microbial.  It 
is unlikely that it will reach or impact on sewage treatment processes. 
 
Ecotoxicologically relevant compounds (consider parent and all relevant metabolites requiring 
further assessment from the fate section) 
Compartment   
soil  eugenol 
water  eugenol 
sediment  None 
groundwater  None 
 
 
Classification and proposed labelling with regard to ecotoxicological data (Annex IIA, point 10 
and Annex IIIA, point 12.3) 
  RMS/peer review proposal  
Active substance   R52 
 
  RMS/peer review proposal  
Preparation    R52, S61 
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APPENDIX B – USED COMPOUND CODE(S) 
Code/Trivial name*  Chemical name  Structural formula 
methyleugenol  1,2-Dimethoxy-4-prop-2-en-1-ylbenzene 
O
O
 
* The metabolite name in bold is the name used in the conclusion. 
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ABBREVIATIONS 
1/n  slope of Freundlich isotherm 
λ  wavelength 
  decadic molar extinction coefficient 
°C  degree Celsius (centigrade) 
µg  microgram 
µm  micrometer (micron) 
a.s.  active substance 
AChE  acetylcholinesterase 
ADE  actual dermal exposure 
ADI  acceptable daily intake 
AF  assessment factor 
AOEL  acceptable operator exposure level 
AP  alkaline phosphatase 
AR  applied radioactivity 
ARfD  acute reference dose 
AST  aspartate aminotransferase (SGOT) 
AV  avoidance factor 
BCF  bioconcentration factor 
BUN  blood urea nitrogen 
bw  body weight 
CAS  Chemical Abstracts Service 
CFU  colony forming units 
ChE  cholinesterase 
CI  confidence interval 
CIPAC  Collaborative International Pesticides Analytical Council Limited 
CL  confidence limits 
cm  centimetre 
CS  capsule suspension 
d  day 
DAA  days after application 
DAR  draft assessment report 
DAT  days after treatment 
DDD  daily dietary dose 
DM  dry matter 
DT50  period required for 50 percent disappearance (define method of estimation) 
DT90  period required for 90 percent disappearance (define method of estimation) 
dw  dry weight 
EbC50  effective concentration (biomass) 
EC50  effective concentration 
ECHA  European Chemical Agency 
EEC  European Economic Community 
EINECS  European Inventory of Existing Commercial Chemical Substances 
ELINCS  European List of New Chemical Substances 
EMDI  estimated maximum daily intake 
ER50  emergence rate/effective rate, median 
ErC50  effective concentration (growth rate) 
EU  European Union 
EUROPOEM  European Predictive Operator Exposure Model 
f(twa)  time weighted average factor 
FAO  Food and Agriculture Organisation of the United Nations 
FID  flame ionisation detector 
FIR  Food intake rate 
FOB  functional observation battery Peer review of the pesticide risk assessment of the active substance eugenol 
 
EFSA Journal 2012;10(11):2914    45 
FOCUS  Forum for the Co-ordination of Pesticide Fate Models and their Use 
g  gram 
GAP  good agricultural practice 
GC  gas chromatography 
GCPF  Global Crop Protection Federation (formerly known as GIFAP) 
GGT  gamma glutamyl transferase 
GM  geometric mean 
GS  growth stage 
GSH  glutathion 
h  hour(s) 
ha  hectare 
Hb  haemoglobin 
Hct  haematocrit 
hL  hectolitre 
HPLC  high pressure liquid chromatography  
or high performance liquid chromatography 
HPLC-MS  high pressure liquid chromatography – mass spectrometry 
HQ  hazard quotient 
IEDI  international estimated daily intake 
IESTI  international estimated short-term intake 
ISO  International Organisation for Standardisation 
IUPAC  International Union of Pure and Applied Chemistry 
JMPR  Joint Meeting on the FAO Panel of Experts on Pesticide Residues in Food and 
the  Environment  and  the  WHO  Expert  Group  on  Pesticide  Residues  (Joint 
Meeting on Pesticide Residues) 
Kdoc  organic carbon linear adsorption coefficient 
kg  kilogram 
KFoc  Freundlich organic carbon adsorption coefficient 
L  litre 
LC  liquid chromatography 
LC50  lethal concentration, median 
LC-MS  liquid chromatography-mass spectrometry 
LC-MS-MS  liquid chromatography with tandem mass spectrometry 
LD50  lethal dose, median; dosis letalis media 
LDH  lactate dehydrogenase 
LOAEL  lowest observable adverse effect level 
LOD  limit of detection 
LOQ  limit of quantification (determination) 
m  metre 
M/L  mixing and loading 
MAF  multiple application factor 
MCH  mean corpuscular haemoglobin 
MCHC  mean corpuscular haemoglobin concentration 
MCV  mean corpuscular volume 
mg  milligram 
mL  millilitre 
mm  millimetre 
mN  milli-newton 
MRL  maximum residue limit or level 
MS  mass spectrometry 
MSDS  material safety data sheet 
MTD  maximum tolerated dose 
MWHC  maximum water holding capacity 
NESTI  national estimated short-term intake 
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NOAEC  no observed adverse effect concentration 
NOAEL  no observed adverse effect level 
NOEC  no observed effect concentration 
NOEL  no observed effect level 
OECD  Organisation for Economic Co-operation and Development  
OM  organic matter content 
Pa  pascal 
PD  proportion of different food types 
PEC  predicted environmental concentration 
PECair  predicted environmental concentration in air 
PECgw  predicted environmental concentration in ground water 
PECsed  predicted environmental concentration in sediment 
PECsoil  predicted environmental concentration in soil 
PECsw  predicted environmental concentration in surface water 
pH  pH-value 
PHED  pesticide handler's exposure data 
PHI  pre-harvest interval 
PIE  potential inhalation exposure 
pKa  negative logarithm (to the base 10) of the dissociation constant 
Pow  partition coefficient between n-octanol and water 
PPE  personal protective equipment 
ppm  parts per million (10
-6) 
ppp  plant protection product 
PT  proportion of diet obtained in the treated area 
PTT  partial thromboplastin time 
r
2  coefficient of determination 
REACH  Registration, Evaluation, Authorisation of CHemicals  
RPE  respiratory protective equipment 
RUD  residue per unit dose 
SC  suspension concentrate 
SD  standard deviation 
SFO  single first-order 
SSD  species sensitivity distribution 
STMR  supervised trials median residue 
t1/2  half-life (define method of estimation) 
TER  toxicity exposure ratio 
TERA  toxicity exposure ratio for acute exposure 
TERLT  toxicity exposure ratio following chronic exposure 
TERST  toxicity exposure ratio following repeated exposure 
TK  technical concentrate 
TLV  threshold limit value 
TMDI  theoretical maximum daily intake 
TRR  total radioactive residue 
TSH  thyroid stimulating hormone (thyrotropin) 
TWA  time weighted average 
UDS  unscheduled DNA synthesis 
UV  ultraviolet 
W/S  water/sediment 
w/v  weight per volume 
w/w  weight per weight 
WG  water dispersible granule 
wk  week 
yr  year 
 